Betula verrucosa for treating moderate to severe allergic rhinitis or conjunctivitis caused by tree pollen

  • Technology appraisal guidance
  • TA1087
  • Published: 

Suggested remit: To appraise the clinical and cost effectiveness of Betula verrucosa within its marketing authorisation for treating rhinoconjunctivitis.

This page was last updated: